Eintrag weiter verarbeiten
Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system
Gespeichert in:
Zeitschriftentitel: | Revista da Associação Médica Brasileira |
---|---|
Personen und Körperschaften: | , , , , , , , , |
In: | Revista da Associação Médica Brasileira, 58, 2012, 3, S. 294-301 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Elsevier BV
|
Schlagwörter: |
author_facet |
Nita, Marcelo Eidi Eliaschewitz, Freddy G. Ribeiro, Eliane Asano, Elio Barbosa, Elias Takemoto, Maíra Donato, Bonnie Rached, Roberto Rahal, Elaine Nita, Marcelo Eidi Eliaschewitz, Freddy G. Ribeiro, Eliane Asano, Elio Barbosa, Elias Takemoto, Maíra Donato, Bonnie Rached, Roberto Rahal, Elaine |
---|---|
author |
Nita, Marcelo Eidi Eliaschewitz, Freddy G. Ribeiro, Eliane Asano, Elio Barbosa, Elias Takemoto, Maíra Donato, Bonnie Rached, Roberto Rahal, Elaine |
spellingShingle |
Nita, Marcelo Eidi Eliaschewitz, Freddy G. Ribeiro, Eliane Asano, Elio Barbosa, Elias Takemoto, Maíra Donato, Bonnie Rached, Roberto Rahal, Elaine Revista da Associação Médica Brasileira Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system General Medicine |
author_sort |
nita, marcelo eidi |
spelling |
Nita, Marcelo Eidi Eliaschewitz, Freddy G. Ribeiro, Eliane Asano, Elio Barbosa, Elias Takemoto, Maíra Donato, Bonnie Rached, Roberto Rahal, Elaine 0104-4230 Elsevier BV General Medicine http://dx.doi.org/10.1016/s0104-4230(12)70198-7 Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system Revista da Associação Médica Brasileira |
doi_str_mv |
10.1016/s0104-4230(12)70198-7 |
facet_avail |
Online Free |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMDEwNC00MjMwKDEyKTcwMTk4LTc |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMDEwNC00MjMwKDEyKTcwMTk4LTc |
institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
imprint |
Elsevier BV, 2012 |
imprint_str_mv |
Elsevier BV, 2012 |
issn |
0104-4230 |
issn_str_mv |
0104-4230 |
language |
English |
mega_collection |
Elsevier BV (CrossRef) |
match_str |
nita2012costeffectivenessandbudgetimpactofsaxagliptineasadditionaltherapytometforminforthetreatmentofdiabetesmellitustype2inthebrazilianprivatehealthsystem |
publishDateSort |
2012 |
publisher |
Elsevier BV |
recordtype |
ai |
record_format |
ai |
series |
Revista da Associação Médica Brasileira |
source_id |
49 |
title |
Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_unstemmed |
Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_full |
Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_fullStr |
Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_full_unstemmed |
Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_short |
Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_sort |
cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the brazilian private health system |
topic |
General Medicine |
url |
http://dx.doi.org/10.1016/s0104-4230(12)70198-7 |
publishDate |
2012 |
physical |
294-301 |
description |
|
container_issue |
3 |
container_start_page |
294 |
container_title |
Revista da Associação Médica Brasileira |
container_volume |
58 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792330464493568003 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T13:25:29.833Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Cost-effectiveness+and+budget+impact+of+saxagliptine+as+additional+therapy+to+metformin+for+the+treatment+of+diabetes+mellitus+type+2+in+the+Brazilian+private+health+system&rft.date=2012-05-01&genre=article&issn=0104-4230&volume=58&issue=3&spage=294&epage=301&pages=294-301&jtitle=Revista+da+Associa%C3%A7%C3%A3o+M%C3%A9dica+Brasileira&atitle=Cost-effectiveness+and+budget+impact+of+saxagliptine+as+additional+therapy+to+metformin+for+the+treatment+of+diabetes+mellitus+type+2+in+the+Brazilian+private+health+system&aulast=Rahal&aufirst=Elaine&rft_id=info%3Adoi%2F10.1016%2Fs0104-4230%2812%2970198-7&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792330464493568003 |
author | Nita, Marcelo Eidi, Eliaschewitz, Freddy G., Ribeiro, Eliane, Asano, Elio, Barbosa, Elias, Takemoto, Maíra, Donato, Bonnie, Rached, Roberto, Rahal, Elaine |
author_facet | Nita, Marcelo Eidi, Eliaschewitz, Freddy G., Ribeiro, Eliane, Asano, Elio, Barbosa, Elias, Takemoto, Maíra, Donato, Bonnie, Rached, Roberto, Rahal, Elaine, Nita, Marcelo Eidi, Eliaschewitz, Freddy G., Ribeiro, Eliane, Asano, Elio, Barbosa, Elias, Takemoto, Maíra, Donato, Bonnie, Rached, Roberto, Rahal, Elaine |
author_sort | nita, marcelo eidi |
container_issue | 3 |
container_start_page | 294 |
container_title | Revista da Associação Médica Brasileira |
container_volume | 58 |
description | |
doi_str_mv | 10.1016/s0104-4230(12)70198-7 |
facet_avail | Online, Free |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMDEwNC00MjMwKDEyKTcwMTk4LTc |
imprint | Elsevier BV, 2012 |
imprint_str_mv | Elsevier BV, 2012 |
institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
issn | 0104-4230 |
issn_str_mv | 0104-4230 |
language | English |
last_indexed | 2024-03-01T13:25:29.833Z |
match_str | nita2012costeffectivenessandbudgetimpactofsaxagliptineasadditionaltherapytometforminforthetreatmentofdiabetesmellitustype2inthebrazilianprivatehealthsystem |
mega_collection | Elsevier BV (CrossRef) |
physical | 294-301 |
publishDate | 2012 |
publishDateSort | 2012 |
publisher | Elsevier BV |
record_format | ai |
recordtype | ai |
series | Revista da Associação Médica Brasileira |
source_id | 49 |
spelling | Nita, Marcelo Eidi Eliaschewitz, Freddy G. Ribeiro, Eliane Asano, Elio Barbosa, Elias Takemoto, Maíra Donato, Bonnie Rached, Roberto Rahal, Elaine 0104-4230 Elsevier BV General Medicine http://dx.doi.org/10.1016/s0104-4230(12)70198-7 Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system Revista da Associação Médica Brasileira |
spellingShingle | Nita, Marcelo Eidi, Eliaschewitz, Freddy G., Ribeiro, Eliane, Asano, Elio, Barbosa, Elias, Takemoto, Maíra, Donato, Bonnie, Rached, Roberto, Rahal, Elaine, Revista da Associação Médica Brasileira, Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system, General Medicine |
title | Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_full | Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_fullStr | Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_full_unstemmed | Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_short | Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
title_sort | cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the brazilian private health system |
title_unstemmed | Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system |
topic | General Medicine |
url | http://dx.doi.org/10.1016/s0104-4230(12)70198-7 |